Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News & Opinion

News and Opinion from the Pandemic Sciences Institute at the University of Oxford

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

The designation recognises the vaccine’s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.

PSI's Omar El Muhanna awarded Jordanian Order for Distinction

This honour comes in recognition of Mr El Muhanna's outstanding contributions to the field of biomanufacturing and his contributions to international patents.

New research published on maximising mpox vaccine availability

Scientists have studied the immune response of a dose-sparing regimen to expand vaccine supply and protect more people from mpox.

First validated tool to measure stigma during multiple infectious disease outbreaks published

The new RAPID Stigma Scales, led by researchers at the PSI, will help health professionals to monitor stigma in disease outbreak settings, improving outbreak responses globally.

Two new Associate Professorships demonstrate PSI’s impact in research, teaching and practice

The title recognises the researchers’ “significant and sustained academic contribution” to the University.

Portrait of Alice Norton

The new Pandemic Agreement offers a glimmer of hope that no country will face future pandemic threats alone

Professor Alice Norton reflects on what the new Pandemic Agreement means for global health security.

Sarah Gilbert receives Royal Society of Chemistry Honorary Fellowship

PSI Principal Investigator Professor Dame Sarah Gilbert has been made an Honorary Fellow of the Royal Society of Chemistry.

Delegates in a packed conference room watching presentation

Speakers announced for this year’s International Pandemic Sciences Conference

Meet the global experts set to present on the latest scientific advancements that will predict, identify and control future epidemic and pandemic threats.

Photograph of a young boy sat up on a bed in a hospital. A health care provider wearing a white coat and a mask is checking his pulse at his wrist.

Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.

Scientist working on a lab bench.

New science partnership to strengthen Africa’s pandemic resilience

A groundbreaking research partnership is set to enhance Africa’s preparedness and response to future health crises.

RECOVERY trial team win NIHR Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact”.

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

New paper outlines ethical issues in clinical metagenomics

This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.

Extended abstract deadline for International Pandemic Sciences Conference 2025

The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025  has been extended to 23:59 GMT on Wednesday 26 February.

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.

New partnership to advance public health and life science research collaboration in West Africa

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Abstract submissions open for International Pandemic Sciences Conference 2025

Abstract and bursary submissions are now open for the International Pandemic Sciences Conference 2025 – Getting Ahead of the Curve.

Study provides new insights into mpox clinical outcomes and transmission

Results of MOSAIC, a European observational study led by researchers at PSI and ISARIC, provides evidence on how the clade IIb mpox virus affects patients and the risks of onward transmission.

Pig research paves way for human respiratory vaccine development

A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.

A group of attendees listening to the conference talks.

Registration now open for International Pandemic Sciences Conference 2025

Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.

Load More